世界の前臨床画像（In-VIVO）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Preclinical Imaging (In-VIVO) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4748
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、前臨床画像（In-VIVO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬）、用途別市場規模（腫瘍、心臓＆血管、神経、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・前臨床画像（In-VIVO）の市場動向
・企業の競争状況、市場シェア
・前臨床画像（In-VIVO）の種類別市場規模（機器、試薬）
・前臨床画像（In-VIVO）の用途別市場規模（腫瘍、心臓＆血管、神経、その他）
・前臨床画像（In-VIVO）の北米市場規模2016-2027（アメリカ、カナダ）
・前臨床画像（In-VIVO）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・前臨床画像（In-VIVO）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・前臨床画像（In-VIVO）の中南米市場規模2016-2027（メキシコ、ブラジル）
・前臨床画像（In-VIVO）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（PerkinElmer、Bruker Corporation、FUJIFILM Holdings、Mediso、MILabs B.V.、MR Solutions、Aspect Imaging、LI-COR Biosciences、Trifoil Imaging、Miltenyi Biotec）
・結論

Market Analysis and Insights: Global Preclinical Imaging (In-VIVO) Market
The global Preclinical Imaging (In-VIVO) market size is projected to reach US$ 862.1 million by 2026, from US$ 675 million in 2019, at a CAGR of 3.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical Imaging (In-VIVO) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical Imaging (In-VIVO) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical Imaging (In-VIVO) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical Imaging (In-VIVO) market.

Global Preclinical Imaging (In-VIVO) Scope and Market Size
Preclinical Imaging (In-VIVO) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical Imaging (In-VIVO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Equipment
Reagent

Segment by Application
Oncology
Cardio and Vascular
Neurology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
PerkinElmer
Bruker Corporation
FUJIFILM Holdings
Mediso
MILabs B.V.
MR Solutions
Aspect Imaging
LI-COR Biosciences
Trifoil Imaging

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Imaging (In-VIVO) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Equipment
1.2.3 Reagent
1.3 Market by Application
1.3.1 Global Preclinical Imaging (In-VIVO) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardio and Vascular
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preclinical Imaging (In-VIVO) Market Perspective (2016-2027)
2.2 Preclinical Imaging (In-VIVO) Growth Trends by Regions
2.2.1 Preclinical Imaging (In-VIVO) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preclinical Imaging (In-VIVO) Historic Market Share by Regions (2016-2021)
2.2.3 Preclinical Imaging (In-VIVO) Forecasted Market Size by Regions (2022-2027)
2.3 Preclinical Imaging (In-VIVO) Industry Dynamic
2.3.1 Preclinical Imaging (In-VIVO) Market Trends
2.3.2 Preclinical Imaging (In-VIVO) Market Drivers
2.3.3 Preclinical Imaging (In-VIVO) Market Challenges
2.3.4 Preclinical Imaging (In-VIVO) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preclinical Imaging (In-VIVO) Players by Revenue
3.1.1 Global Top Preclinical Imaging (In-VIVO) Players by Revenue (2016-2021)
3.1.2 Global Preclinical Imaging (In-VIVO) Revenue Market Share by Players (2016-2021)
3.2 Global Preclinical Imaging (In-VIVO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preclinical Imaging (In-VIVO) Revenue
3.4 Global Preclinical Imaging (In-VIVO) Market Concentration Ratio
3.4.1 Global Preclinical Imaging (In-VIVO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Imaging (In-VIVO) Revenue in 2020
3.5 Preclinical Imaging (In-VIVO) Key Players Head office and Area Served
3.6 Key Players Preclinical Imaging (In-VIVO) Product Solution and Service
3.7 Date of Enter into Preclinical Imaging (In-VIVO) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical Imaging (In-VIVO) Breakdown Data by Type
4.1 Global Preclinical Imaging (In-VIVO) Historic Market Size by Type (2016-2021)
4.2 Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Type (2022-2027)

5 Preclinical Imaging (In-VIVO) Breakdown Data by Application
5.1 Global Preclinical Imaging (In-VIVO) Historic Market Size by Application (2016-2021)
5.2 Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preclinical Imaging (In-VIVO) Market Size (2016-2027)
6.2 North America Preclinical Imaging (In-VIVO) Market Size by Type
6.2.1 North America Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021)
6.2.2 North America Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027)
6.2.3 North America Preclinical Imaging (In-VIVO) Market Size by Type (2016-2027)
6.3 North America Preclinical Imaging (In-VIVO) Market Size by Application
6.3.1 North America Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021)
6.3.2 North America Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027)
6.3.3 North America Preclinical Imaging (In-VIVO) Market Size by Application (2016-2027)
6.4 North America Preclinical Imaging (In-VIVO) Market Size by Country
6.4.1 North America Preclinical Imaging (In-VIVO) Market Size by Country (2016-2021)
6.4.2 North America Preclinical Imaging (In-VIVO) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Preclinical Imaging (In-VIVO) Market Size (2016-2027)
7.2 Europe Preclinical Imaging (In-VIVO) Market Size by Type
7.2.1 Europe Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021)
7.2.2 Europe Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027)
7.2.3 Europe Preclinical Imaging (In-VIVO) Market Size by Type (2016-2027)
7.3 Europe Preclinical Imaging (In-VIVO) Market Size by Application
7.3.1 Europe Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021)
7.3.2 Europe Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027)
7.3.3 Europe Preclinical Imaging (In-VIVO) Market Size by Application (2016-2027)
7.4 Europe Preclinical Imaging (In-VIVO) Market Size by Country
7.4.1 Europe Preclinical Imaging (In-VIVO) Market Size by Country (2016-2021)
7.4.2 Europe Preclinical Imaging (In-VIVO) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size (2016-2027)
8.2 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Type
8.2.1 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Type (2016-2027)
8.3 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Application
8.3.1 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Application (2016-2027)
8.4 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region
8.4.1 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preclinical Imaging (In-VIVO) Market Size (2016-2027)
9.2 Latin America Preclinical Imaging (In-VIVO) Market Size by Type
9.2.1 Latin America Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021)
9.2.2 Latin America Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027)
9.2.3 Latin America Preclinical Imaging (In-VIVO) Market Size by Type (2016-2027)
9.3 Latin America Preclinical Imaging (In-VIVO) Market Size by Application
9.3.1 Latin America Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021)
9.3.2 Latin America Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027)
9.3.3 Latin America Preclinical Imaging (In-VIVO) Market Size by Application (2016-2027)
9.4 Latin America Preclinical Imaging (In-VIVO) Market Size by Country
9.4.1 Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2016-2021)
9.4.2 Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size (2016-2027)
10.2 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Type
10.2.1 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Type (2016-2027)
10.3 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Application
10.3.1 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Application (2016-2027)
10.4 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country
10.4.1 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Details
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer Preclinical Imaging (In-VIVO) Introduction
11.1.4 PerkinElmer Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.1.5 PerkinElmer Recent Development
11.2 Bruker Corporation
11.2.1 Bruker Corporation Company Details
11.2.2 Bruker Corporation Business Overview
11.2.3 Bruker Corporation Preclinical Imaging (In-VIVO) Introduction
11.2.4 Bruker Corporation Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.2.5 Bruker Corporation Recent Development
11.3 FUJIFILM Holdings
11.3.1 FUJIFILM Holdings Company Details
11.3.2 FUJIFILM Holdings Business Overview
11.3.3 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Introduction
11.3.4 FUJIFILM Holdings Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.3.5 FUJIFILM Holdings Recent Development
11.4 Mediso
11.4.1 Mediso Company Details
11.4.2 Mediso Business Overview
11.4.3 Mediso Preclinical Imaging (In-VIVO) Introduction
11.4.4 Mediso Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.4.5 Mediso Recent Development
11.5 MILabs B.V.
11.5.1 MILabs B.V. Company Details
11.5.2 MILabs B.V. Business Overview
11.5.3 MILabs B.V. Preclinical Imaging (In-VIVO) Introduction
11.5.4 MILabs B.V. Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.5.5 MILabs B.V. Recent Development
11.6 MR Solutions
11.6.1 MR Solutions Company Details
11.6.2 MR Solutions Business Overview
11.6.3 MR Solutions Preclinical Imaging (In-VIVO) Introduction
11.6.4 MR Solutions Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.6.5 MR Solutions Recent Development
11.7 Aspect Imaging
11.7.1 Aspect Imaging Company Details
11.7.2 Aspect Imaging Business Overview
11.7.3 Aspect Imaging Preclinical Imaging (In-VIVO) Introduction
11.7.4 Aspect Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.7.5 Aspect Imaging Recent Development
11.8 LI-COR Biosciences
11.8.1 LI-COR Biosciences Company Details
11.8.2 LI-COR Biosciences Business Overview
11.8.3 LI-COR Biosciences Preclinical Imaging (In-VIVO) Introduction
11.8.4 LI-COR Biosciences Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.8.5 LI-COR Biosciences Recent Development
11.9 Trifoil Imaging
11.9.1 Trifoil Imaging Company Details
11.9.2 Trifoil Imaging Business Overview
11.9.3 Trifoil Imaging Preclinical Imaging (In-VIVO) Introduction
11.9.4 Trifoil Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.9.5 Trifoil Imaging Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Details
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Preclinical Imaging (In-VIVO) Introduction
11.10.4 Miltenyi Biotec Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021)
11.10.5 Miltenyi Biotec Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preclinical Imaging (In-VIVO) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Equipment
Table 3. Key Players of Reagent
Table 4. Global Preclinical Imaging (In-VIVO) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Preclinical Imaging (In-VIVO) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Preclinical Imaging (In-VIVO) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Preclinical Imaging (In-VIVO) Market Share by Regions (2016-2021)
Table 8. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Preclinical Imaging (In-VIVO) Market Share by Regions (2022-2027)
Table 10. Preclinical Imaging (In-VIVO) Market Trends
Table 11. Preclinical Imaging (In-VIVO) Market Drivers
Table 12. Preclinical Imaging (In-VIVO) Market Challenges
Table 13. Preclinical Imaging (In-VIVO) Market Restraints
Table 14. Global Preclinical Imaging (In-VIVO) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Preclinical Imaging (In-VIVO) Market Share by Players (2016-2021)
Table 16. Global Top Preclinical Imaging (In-VIVO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical Imaging (In-VIVO) as of 2020)
Table 17. Ranking of Global Top Preclinical Imaging (In-VIVO) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Preclinical Imaging (In-VIVO) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Preclinical Imaging (In-VIVO) Product Solution and Service
Table 21. Date of Enter into Preclinical Imaging (In-VIVO) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type (2016-2021)
Table 25. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Preclinical Imaging (In-VIVO) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Application (2016-2021)
Table 29. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Preclinical Imaging (In-VIVO) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Preclinical Imaging (In-VIVO) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Preclinical Imaging (In-VIVO) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Preclinical Imaging (In-VIVO) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2022-2027) & (US$ Million)
Table 61. PerkinElmer Company Details
Table 62. PerkinElmer Business Overview
Table 63. PerkinElmer Preclinical Imaging (In-VIVO) Product
Table 64. PerkinElmer Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 65. PerkinElmer Recent Development
Table 66. Bruker Corporation Company Details
Table 67. Bruker Corporation Business Overview
Table 68. Bruker Corporation Preclinical Imaging (In-VIVO) Product
Table 69. Bruker Corporation Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 70. Bruker Corporation Recent Development
Table 71. FUJIFILM Holdings Company Details
Table 72. FUJIFILM Holdings Business Overview
Table 73. FUJIFILM Holdings Preclinical Imaging (In-VIVO) Product
Table 74. FUJIFILM Holdings Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 75. FUJIFILM Holdings Recent Development
Table 76. Mediso Company Details
Table 77. Mediso Business Overview
Table 78. Mediso Preclinical Imaging (In-VIVO) Product
Table 79. Mediso Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 80. Mediso Recent Development
Table 81. MILabs B.V. Company Details
Table 82. MILabs B.V. Business Overview
Table 83. MILabs B.V. Preclinical Imaging (In-VIVO) Product
Table 84. MILabs B.V. Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 85. MILabs B.V. Recent Development
Table 86. MR Solutions Company Details
Table 87. MR Solutions Business Overview
Table 88. MR Solutions Preclinical Imaging (In-VIVO) Product
Table 89. MR Solutions Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 90. MR Solutions Recent Development
Table 91. Aspect Imaging Company Details
Table 92. Aspect Imaging Business Overview
Table 93. Aspect Imaging Preclinical Imaging (In-VIVO) Product
Table 94. Aspect Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 95. Aspect Imaging Recent Development
Table 96. LI-COR Biosciences Company Details
Table 97. LI-COR Biosciences Business Overview
Table 98. LI-COR Biosciences Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 99. LI-COR Biosciences Recent Development
Table 100. Trifoil Imaging Company Details
Table 101. Trifoil Imaging Business Overview
Table 102. Trifoil Imaging Preclinical Imaging (In-VIVO) Product
Table 103. Trifoil Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 104. Trifoil Imaging Recent Development
Table 105. Miltenyi Biotec Company Details
Table 106. Miltenyi Biotec Business Overview
Table 107. Miltenyi Biotec Preclinical Imaging (In-VIVO) Product
Table 108. Miltenyi Biotec Revenue in Preclinical Imaging (In-VIVO) Business (2016-2021) & (US$ Million)
Table 109. Miltenyi Biotec Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical Imaging (In-VIVO) Market Share by Type: 2020 VS 2027
Figure 2. Equipment Features
Figure 3. Reagent Features
Figure 4. Global Preclinical Imaging (In-VIVO) Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Cardio and Vascular Case Studies
Figure 7. Neurology Case Studies
Figure 8. Others Case Studies
Figure 9. Preclinical Imaging (In-VIVO) Report Years Considered
Figure 10. Global Preclinical Imaging (In-VIVO) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Preclinical Imaging (In-VIVO) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Preclinical Imaging (In-VIVO) Market Share by Regions: 2020 VS 2027
Figure 13. Global Preclinical Imaging (In-VIVO) Market Share by Regions (2022-2027)
Figure 14. Global Preclinical Imaging (In-VIVO) Market Share by Players in 2020
Figure 15. Global Top Preclinical Imaging (In-VIVO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical Imaging (In-VIVO) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Preclinical Imaging (In-VIVO) Revenue in 2020
Figure 17. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type (2016-2021)
Figure 18. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type (2022-2027)
Figure 19. North America Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Preclinical Imaging (In-VIVO) Market Share by Type (2016-2027)
Figure 21. North America Preclinical Imaging (In-VIVO) Market Share by Application (2016-2027)
Figure 22. North America Preclinical Imaging (In-VIVO) Market Share by Country (2016-2027)
Figure 23. United States Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Preclinical Imaging (In-VIVO) Market Share by Type (2016-2027)
Figure 27. Europe Preclinical Imaging (In-VIVO) Market Share by Application (2016-2027)
Figure 28. Europe Preclinical Imaging (In-VIVO) Market Share by Country (2016-2027)
Figure 29. Germany Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Preclinical Imaging (In-VIVO) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Preclinical Imaging (In-VIVO) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Preclinical Imaging (In-VIVO) Market Share by Region (2016-2027)
Figure 39. China Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Preclinical Imaging (In-VIVO) Market Share by Type (2016-2027)
Figure 47. Latin America Preclinical Imaging (In-VIVO) Market Share by Application (2016-2027)
Figure 48. Latin America Preclinical Imaging (In-VIVO) Market Share by Country (2016-2027)
Figure 49. Mexico Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Preclinical Imaging (In-VIVO) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Preclinical Imaging (In-VIVO) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Preclinical Imaging (In-VIVO) Market Share by Country (2016-2027)
Figure 55. Turkey Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Preclinical Imaging (In-VIVO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. PerkinElmer Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 59. Bruker Corporation Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 60. FUJIFILM Holdings Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 61. Mediso Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 62. MILabs B.V. Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 63. MR Solutions Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 64. Aspect Imaging Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 65. LI-COR Biosciences Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 66. Trifoil Imaging Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 67. Miltenyi Biotec Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global In-vivo Contract Research Organization Market Size, Status and Forecast 2021-2027
QYR2104Z3251 2021年4月 99Pages
QYResearch社発行の本調査資料では、In-vivo 医薬品開発受託機関のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（げっ歯類、非げっ歯類）、用途別市場規模（自己免疫、疼痛管理、腫瘍、中枢神経系、糖尿病、肥満、その他）、主要地域別市場規...

世界のIn Vivo CRO市場規模・現状・予測（2021年-2027年）

Global In Vivo CRO Market Size, Status and Forecast 2021-2027
QYR2104Z3077 2021年4月 98Pages
QYResearch社発行の本調査資料では、In Vivo CROのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（げっ歯類、非げっ歯類）、用途別市場規模（自己免疫、疼痛管理、腫瘍、中枢神経系、糖尿病、肥満、その他）、主要地域別市場規模（北米、ア...

世界の小動物用イメージング（In-vivo）市場 2021：企業別、地域別、種類・用途別

Global Small Animal Imaging (In-vivo) Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z12729 2021年4月 101Pages
当調査資料では、小動物用イメージング（In-vivo）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。小動物用イメージング（In-vivo）の種類別市場規模（マイクロMRI、光学、核）、用途別市場規模（治療反応モニタリング、生体内分布、薬物/標的関与決...

世界の磁気共鳴画像（MRI）市場規模・現状・予測（2021年-2027年）

Global Preclinical Magnetic Resonance Imaging (MRI) Market Size, Status and Forecast 2021-2027
QYR2104Z4750 2021年4月 96Pages
QYResearch社発行の本調査資料では、磁気共鳴画像（MRI）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市場規模（北米...

世界の小動物イメージング（生体内）市場規模・現状・予測（2021年-2027年）

Global Small Animal Imaging (In-vivo) Market Size, Status and Forecast 2021-2027
QYR2104Z5292 2021年4月 94Pages
QYResearch社発行の本調査資料では、小動物イメージング（生体内）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（マイクロMRI、光学、核）、用途別市場規模（治療反応モニタリング、体内分布、薬物/標的関与決定、がん細胞検出、バイオマーカー...

世界の小動物イメージング（生体内）市場規模・現状・予測（2021年-2027年）

世界の陽電子放出断層撮影（PET）市場規模・現状・予測（2021年-2027年）

Global Preclinical Positron Emission Tomography (PET) Market Size, Status and Forecast 2021-2027
QYR2104Z4751 2021年4月 92Pages
QYResearch社発行の本調査資料では、陽電子放出断層撮影（PET）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市場規模...

世界の単一光子放射断層撮影（SPECT）市場規模・現状・予測（2021年-2027年）

Global Preclinical Single Photon Emission Computed Tomography (SPECT) Market Size, Status and Forecast 2021-2027
QYR2104Z4752 2021年4月 92Pages
QYResearch社発行の本調査資料では、単一光子放射断層撮影（SPECT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市...

世界の前臨床X線画像市場規模・現状・予測（2021年-2027年）

Global Preclinical X-ray Imaging Market Size, Status and Forecast 2021-2027
QYR2104Z4753 2021年4月 98Pages
QYResearch社発行の本調査資料では、前臨床X線画像のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（構造画像、機能画像）、用途別市場規模（製薬会社、委託研究機関（CRO）、バイオテクノロジー会社、その他）、主要地域別市場規模（北米、アメリ...

世界の前臨床脳画像市場規模・現状・予測（2021年-2027年）

Global Preclinical Brain Imaging Market Size, Status and Forecast 2021-2027
QYR2104Z4746 2021年4月 96Pages
QYResearch社発行の本調査資料では、前臨床脳画像のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コンピュータ断層撮影（CT）、ポジトロン放出断層撮影（PET）、磁気共鳴画像法（MRI）、単一光子放射型コンピュータ断層撮影（SPECT）、...

世界のInVivoイメージングシステム市場規模・現状・予測（2021年-2027年） In Vivo Imaging System are designed to automate in vivo imaging research with one-touch, pre-set or user-defined PC controls for accurate, repeatable imaging. Capture superior images with the high resolution, high sensitivity cooled CCD camera and optics. Ability to image organs and cells subcutane…
世界の小動物イメージング（生体内）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Animal Imaging (In-vivo) Market The global Small Animal Imaging (In-vivo) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…
世界の小動物イメージング（生体内）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Animal Imaging (In-vivo) Market The global Small Animal Imaging (In-vivo) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…
世界の前臨床X線画像市場規模・現状・予測（2021年-2027年） An x-ray (radiograph) is a penetrating form of high-energy electromagnetic radiation and noninvasive medical test that helps physicians diagnose and treat medical conditions. Market Analysis and Insights: Global Preclinical X-ray Imaging Market The global Preclinical X-ray Imaging market size is pr…
世界のIn-vivo 医薬品開発受託機関市場規模・現状・予測（2021年-2027年） In-vivo contract research organizations (CROs) are those institutions engaged in biopharmaceutical research on a contractual basis. With the growing popularity of biologics over small molecule drugs, the popularity of in-vivo CROs are gaining traction. With increasing demand for clinical scale manuf…